Login / Signup

Clinical trial participation improves survival outcomes by increasing availability of new therapeutic agents in multiple myeloma.

Sung Hoon JungJe-Jung LeeGa-Young SongHo Sup LeeSeok Jin KimSang Eun YoonKihyun Kim
Published in: British journal of haematology (2021)
Keyphrases
  • multiple myeloma
  • clinical trial
  • physical activity
  • phase ii
  • open label
  • double blind
  • phase iii
  • randomized controlled trial